Biotecnomed

What Biotecnomed does

Biotecnomed S.c.a.r.l. is a privately-held Italian consortium company founded in 2012 that operates as the designated innovation cluster for life sciences and biotechnology in Calabria, southern Italy. It manages the Polo di Innovazione Tecnologie della Salute and the Distretto ad Alta Tecnologia Salute dell'Uomo e Biotecnologie under the Calabria Region's Smart Specialization Strategy (S3), serving as a network aggregator, shared R&D infrastructure provider, and consortium manager for publicly funded research projects. Its 59-member ecosystem comprises 52 enterprises, 3 private research entities, 2 universities, and the National Research Council (CNR), and it serves as gateway between academic research at Università Magna Græcia di Catanzaro and life-sciences SMEs across regenerative medicine, advanced diagnostics, neuromotor rehabilitation, and nutraceutical/functional food sectors.

The cluster's technology platform spans four thematic laboratory areas backed by shared infrastructure: a regenerative medicine platform with stem cell isolation/expansion and biobanking (ICaRe project); an advanced diagnostics platform spanning neuroimaging, clinical decision support, and bioelectronic devices; a neuromotor rehabilitation platform integrating hardware, sensors, and data mining (LOCUBIRehab family, ANKLEREHAB, KNEEREHAB, UPPERLIMBREHAB); and a nutraceutical platform producing validated functional foods (ALIFUD project). Project outputs include the MATE NB-IoT wearable for vulnerable populations, WEEPIE medication compliance device, EDIPO IoT device for diabetic polyneuropathy, Hearthdrive remote cardiac monitoring platform, Optima Cardiopaths cardiovascular system, and Neuromeasures early-diagnostic support for Parkinson's/Alzheimer's. A maker space provides electronics, informatics, and mechatronics facilities for biomedical prototyping.

Biotecnomed generates no commercial revenue; its funding is derived entirely from EU, national, and regional public grants (POR Calabria FESR-FSE, PON Ricerca, PNRR M4C2), supplemented by 5 per mille tax contributions and project management overhead. Direct allocations across tracked projects total roughly €10M+ over multiple years, while the projects it participates in collectively manage budgets exceeding €160M. The GTM motion is community-led: the cluster recruits member organizations, runs orientation programs (CAL.HUB.RIA – LAB) to convert academic talent into ventures, and channels public innovation funding into the regional economy via cascade calls (bandi a cascata), brokerage events (MIT4LS), and participation in national/international events (BIO DIGITAL USA, MEDICA, Maker Faire Rome). Leadership is drawn from Università Magna Græcia, with Prof. Giuseppe Viglietto serving as President and Prof. Daniele Torella as Scientific Manager.

Name

Biotecnomed

Legal name

Biotecnomed S.c.a.r.l.

Website

https://biotecnomed.it

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Biotecnomed S.c.a.r.l. is a Calabria-based, publicly-funded innovation cluster and consortium manager that aggregates 59 life-sciences enterprises, universities, and CNR around four thematic laboratories (regenerative medicine, advanced diagnostics, neuromotor rehabilitation, nutraceuticals), providing shared R&D infrastructure, IP consulting, and project management for EU, national, and regional grant programs.

Ownership category

akta.pro rank

Product category

Life Sciences R&D Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Life sciences research
• Biomedical R&D services
• Innovation cluster management
• Health technology consulting
• Regenerative medicine research

Headquarters

HQ city

Catanzaro

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. EU and Regional Research Funding Management: Biotecnomed functions as a consortium manager for large-scale publicly funded R&D projects financed by EU and Italian national/regional programs (POR Calabria FESR-FSE 2014-2020, PON MISE I&C 2014-2020, PNRR, POR FSC 2014-2020). It acts as a lead beneficiary or consortium coordinator, receiving and distributing public grants across partner organizations. The organization's own financial sustainability derives from contributions tied to funded project management and operational support.
2. Integrated R&D and Innovation Services: Biotecnomed provides paid-for R&D services, laboratory analyses, intellectual property consulting, training, and maker space access to member companies, research institutions, and external clients. Services include prototyping support, IP protection guidance, laboratory testing, and professional development courses.
3. Innovation Hub Membership and Settlement Fees: Companies and researchers can join the Biotecnomed cluster as members, gaining access to shared infrastructure, networking, and co-innovation opportunities. The hub provides settlement spaces in its Catanzaro facility near the University Magna Græcia campus.
4. 5 per mille Tax Contribution: Italian taxpayers can allocate 5 per mille of their income tax to Biotecnomed as a non-profit research organization, providing a supplementary public funding stream (Fiscal Code: 03152670794).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Biotecnomed is a non-profit R&D consortium that manages the Polo di Innovazione Tecnologie della Salute in Calabria, providing companies, universities, and research bodies with shared laboratory infrastructure, R&D services, intellectual property consulting, training, and a Maker Space across four life sciences thematic areas — regenerative medicine, advanced diagnostics, neuromotor rehabilitation, and nutraceuticals/functional foods. It coordinates publicly funded multi-partner projects (PNRR, POR Calabria, PON) and orchestrates technology transfer between academia and industry.

Product overview

Biotecnomed is a research and development cluster focused on life sciences and health technologies in Calabria, Italy. The organization operates as a platform combining four core service offerings (R&D services, Intellectual Property consulting, Laboratory Research services, and Training/Events) with four specialized research areas (Regenerative Medicine, Advanced Diagnostics, Neuromotor Rehabilitation, and Nutraceuticals/Functional Foods). The portfolio includes numerous research projects producing medical devices such as the MATE wearable assistant, WEEPIE medication compliance device, EDIPO diabetic neuropathy evaluator, rehabilitation devices (LOCOREHAB, ANKLEREHAB, KNEEREHAB, UPPERLIMBREHAB), monitoring platforms (Hearthdrive), cardiovascular systems (Optima Cardiopaths), and AI-enabled diagnostic support services (Neuromeasures). Biotecnomed also operates a Maker Space facility for digital fabrication of biomedical prototypes.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 3 functional food products developed and validated in clinical trials (ALIFUD): antioxidant-enriched milk, whey-protein-enriched ice cream, carotenoid-rich tomato sauce, demonstrating reduction in bone turnover markers and fracture risk reduction in postmenopausal osteoporosis patients.
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

18 partnerships are on record, tiered core, minor and moderate.

• InvitaliacoreStrategic or Co-development PartnerInvitalia is the Italian national agency for investment promotion and economic development. Biotecnomed is listed as a Partner on the Invitalia Startup System 2023, indicating formal collaboration in supporting startup ecosystems and innovation in Calabria.
• Tech4You S.c.a.r.l.coreStrategic or Co-development PartnerTech4You is the consortium managing the PNRR-funded Tech4You ecosystem (€122.1M total). Biotecnomed Scarl participates as a member of Spoke 5 (Technologies for healthy nutrition and resilient communities), led by Università Magna Graecia of Catanzaro, alongside Università della Calabria and EPITECH Group SpA. Biotecnomed contributes to wearable IoT device development for wellness farm experiences.
• Università Magna Græcia di CatanzarocoreStrategic or Co-development PartnerUniversità Magna Græcia (UMG) of Catanzaro is the primary academic partner, co-hosting Biotecnomed's headquarters on its campus (level 2, Corpo G). UMG researchers participate in nearly all Biotecnomed R&D projects as co-investigators, including WEEPIE, MATE, NADITEMM, ALIFUD, MOLIM, ICaRe, Hearthdrive, and the MERCK nutraceutical project. UMG's Prof. Giuseppe Viglietto serves as President of Biotecnomed scarl.
• CNR (National Research Council of Italy)coreStrategic or Co-development PartnerThe National Research Council (CNR) is a member of the Polo di Innovazione Tecnologie della Salute (2018-2022) and a co-investigator on multiple R&D projects, including the Neuromeasures project (early diagnosis of Parkinson's and Alzheimer's), contributing to biomarker research and computational neuroscience capabilities.
• Merck Serono S.p.A.coreStrategic or Co-development PartnerMerck Serono S.p.A. partnered with Biotecnomed in the Progetto Merck (2020-2023, €3.1M total investment, €1.5M EU contribution) and the follow-on GENADIS-D project, developing a nutraceutical for male and female infertility. Merck Serono is responsible for industrial-scale formulation and eventual market launch of the nutraceutical product, while Biotecnomed and UMG conduct the scientific research and bioinformatics analysis.
• Bugnion S.p.A.minorImplementation/ SI/ Consulting PartnerBugnion S.p.A., a leading Italian and European intellectual property consultancy, collaborates with Biotecnomed on technology transfer seminars and IP protection workshops, helping researchers and entrepreneurs navigate the patent registration and brand naming process.
• MIT4LS – Meet in Italy for Life Sciences / ALISEI ClustermoderateStrategic or Co-development PartnerBiotecnomed participates in the ALISEI National Life Sciences Technology Cluster and the MIT4LS international brokerage platform, connecting with other Italian life sciences clusters and facilitating cross-regional and international R&D partnerships and business matching.
• Università della Calabria (Unical)coreStrategic or Co-development PartnerUniversità della Calabria is a member of the Polo di Innovazione Tecnologie della Salute and a partner in projects including NADITEMM, Hearthdrive, and Tech4You. It provides research capacity in computational biology, bioengineering, and clinical research across Calabria's academic ecosystem.
• CNR (co-attuatore in Neuromeasures)coreStrategic or Co-development PartnerCNR serves as co-attuatore (co-implementing body) in the Neuromeasures project, contributing to the development of early diagnostic support services for Parkinson's and Alzheimer's disease and the associated innovative processes.
• Enterprise Europe Network (EEN)minorStrategic or Co-development PartnerBiotecnomed collaborates with Unioncamere Calabria as a partner in the Enterprise Europe Network, facilitating international brokerage, cross-border partnerships, and access to European innovation funding opportunities for Calabrian life sciences companies.
• Università degli Studi di MessinaminorStrategic or Co-development PartnerThe University of Messina participates in the MOLIM molecular imaging project, contributing to oncological and neurodegenerative disease imaging research alongside Calabrian universities.
• Università degli Studi di Milano – BicoccaminorStrategic or Co-development PartnerUniversità degli Studi di Milano – Bicocca is a partner in the MOLIM project, contributing to molecular imaging and radiomics research for oncological and neurodegenerative disease studies.
• Università degli Studi di TorinominorStrategic or Co-development PartnerUniversità degli Studi di Torino participates in the MOLIM project, contributing advanced molecular imaging capabilities and expertise to the oncological and neurodegenerative disease research network.
• DHITECH – Distretto Tecnologico High-Tech S.c.a.r.l.minorStrategic or Co-development PartnerDHITECH (Apulia High-Tech District) partners in the CADS project, contributing expertise in smart living technologies and emergency virtual room development for domestic safety.
• UKE – Università Kore di EnnaminorStrategic or Co-development PartnerUniversità Kore di Enna is a partner in the CADS project, contributing academic research capacity to the development of virtual emergency room and smart living technologies.
• Università Magna Græcia di Catanzaro – DMSCcoreStrategic or Co-development PartnerThe Department of Medical and Surgical Sciences (DMSC) of Università Magna Græcia di Catanzaro conducts clinical studies within the GENADIS-D nutraceutical project, evaluating the impact of the D-Aspartic acid, melatonin, and CoQ10 supplement on gamete quality and reproductive outcomes in couples undergoing assisted reproduction (PMA) cycles.
• Comune di CatanzarominorStrategic or Co-development PartnerThe Municipality of Catanzaro is a partner in the Catanzaro 4.0 project, providing municipal data and governance for the development of digital accessibility services for the city's cultural and environmental heritage.
• Università della CalabriacoreStrategic or Co-development PartnerUniversità della Calabria contributes to the Hearthdrive project, providing computational biology and bioengineering expertise for remote cardiovascular patient monitoring and clinical decision support systems.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BioRegio STERN Management GmbH: German regional biotech cluster (Stuttgart/Tübingen/Neckar-Alb) operating as a network coordinator for life sciences SMEs and academic partners; comparable model for shared innovation services and EU grant intermediation.
• BioM (Munich Biotech Cluster): Leading German biotech cluster management organization with comparable consortium structure, public funding access, and member-network services across pharma, diagnostics, and medical devices — well-established European benchmark for cluster-style life sciences infrastructure.
• Toscana Life Sciences: Italian non-profit foundation managing a life sciences innovation cluster in Siena, with similar consortium structure, public-grant funding model, and focus on biomedical R&D, diagnostics, and therapeutic development. Most structurally comparable Italian peer.
• Distretto Tecnologico High-Tech (DHITECH): Apulia-based high-tech district consortium manager operating under Italy's Smart Specialization Strategy; comparable public-grant funded model and already an existing project partner of Biotecnomed in the CADS project.
• Cluster Lombardo Scienze della Vita: Lombardy-based life sciences innovation cluster and Lombardy Cluster Technology Network member; competes with Biotecnomed for Italian SMEs, EU grants, and PNRR-funded projects in biotech and medical devices.
• BioIndustry Park Silvano Fumero: Italian biotech science park and incubator in Piedmont offering shared laboratory infrastructure, R&D services, and technology transfer support to life sciences companies — directly analogous to Biotecnomed's cluster and Maker Space model.
• Italian Life Sciences Technology Cluster (ALISEI): National-level Italian life sciences cluster of which Biotecnomed is a member; coordinates public funding access and international matchmaking events (MIT4LS), serving as both an aggregator and Biotecnomed's umbrella network.

Regional players

• CataloniaBio & HealthTech: Bioregion of Catalonia's life sciences and health technology cluster serving as the regional innovation hub; comparable consortium/membership model but anchored in a much larger and internationally connected biotech ecosystem.
• Medicon Valley Alliance: Cross-border Danish-Swedish life sciences cluster organization with similar member-network, brokerage, and grant-coordination functions but operating in a far larger and more mature Nordic life sciences ecosystem.

Emerging players

• bioPôle: Swiss life sciences campus and innovation cluster offering shared lab infrastructure and incubator services to biotech and medtech SMEs; comparable shared-infrastructure cluster model operating in a smaller, premium-priced market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/biotecnomed_it

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotecnomed